Executive VP & Chief Product Officer Resigns, Transitions to Advisor Role
NUS sits 24% above its 52-week low of $5.775.
Summary
Nu Skin's Executive Vice President and Chief Product Officer, Steven K. Hatchett, has resigned due to family health reasons but will remain as a strategic product advisor.
Key Events · Executive and Board Changes · NUS
-
Executive Resignation
Steven K. Hatchett resigned from his position as Executive Vice President and Chief Product Officer, effective May 8, 2026.
-
Reason for Departure
The resignation is attributed to family health circumstances.
-
Transition to Advisory Role
Mr. Hatchett will remain with the company as a strategic product advisor with an annual salary of $147,478.
-
Context of Recent Financials
This executive change follows recent reports of a 12% revenue decline and a significant drop in EPS for Q1 2026, as disclosed on May 7th and 8th.
Analysis · NUS · Trade & Services
This filing reports the resignation of Steven K. Hatchett, Executive Vice President and Chief Product Officer, effective May 8, 2026, due to family health circumstances. While the departure of a C-suite executive is generally a negative signal, his transition to a strategic product advisor role provides some continuity. This change occurs amidst recent negative financial results, including a 12% revenue decline and a sharp drop in EPS for Q1 2026, which may amplify investor scrutiny of leadership stability.
At the time of this filing, NUS was trading at $7.16 on NYSE in the Trade & Services sector, with a market capitalization of approximately $352.1M. The 52-week trading range was $5.78 to $14.62. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.